GB2480407A — Autoinjector with locking mechanism at the injection end
Assigned to Intelliject Inc · Expires 2011-11-16 · 15y expired
What this patent protects
An injection device (1000, figure 1) holds a medicament container (12262, figure 16A) which is driven by an energy storage means 3560 such as a spring or a canister of pressurised gas. Operation of the device is caused by movement of a trigger member 3520 forming the base of the …
USPTO Abstract
An injection device (1000, figure 1) holds a medicament container (12262, figure 16A) which is driven by an energy storage means 3560 such as a spring or a canister of pressurised gas. Operation of the device is caused by movement of a trigger member 3520 forming the base of the injector which is disposed partly within and partly outside of the device housing (1100, figure 1). A locking member 3170 is removably coupled to the bottom of the housing and has a protrusion 3174 which engages with projections 3548 on the energy storage means such as cam legs 3548. Whilst the locking member is engaged, the energy storage means cannot be triggered. In operation, the locking member is pulled away from the injector which is then pressed against the patient to trigger the injection.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.